A novel series of benzimidazoles was identified and optimized, leading to the discovery of potent and selective antagonists of the human melanocortin-4 receptor. In addition, compound 5i was shown to cross the blood-brain barrier after intravenous dosing in rats.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmcl.2007.06.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!